- Pharmaceutical Technology's In the Lab eNewsletter 12-02-2020
- Volume 15
- Issue 12
Bio-Rad StarBright Dyes for Flow Cytometry Offer Enhanced Resolution
Made up of Bio-Rad’s validated flow antibodies, the dyes offer maximal brightness and improved resolution of populations and low-density antigens for simple integration into multiplex panels.
StarBright Blue 700, StarBright Violet 440, and StarBright Violet 610 Dyes from Bio-Rad Laboratories are fluorescent nanoparticles designed for flow cytometry.
Made up of Bio-Rad’s validated flow antibodies, the dyes offer maximal brightness and improved resolution of populations and low-density antigens for simple integration into multiplex panels. Benefits of the dyes include:
- Resistance against photobleaching and stability with minimum lot-to-lot variation for consistent and reproducible staining
- Works with all common staining buffers, including special polymer dye staining buffers
- No loss of signal in fixation
- Narrow excitation and emission profiles for enhanced resolution in new and existing flow cytometry experiments.
“StarBright Dyes offer exceptional brightness with specific excitation and emission, allowing researchers to build brighter flow cytometry panels to enable better resolution of positive populations from background without the need for special buffers,” said Mike Blundell, Bio-Rad product manager, Life Science Group, in a Nov. 2, 2020 press release. “The unique profile of these dyes combined with Bio-Rad’s high-quality antibodies provides flexibility and offers a reliable alternative for incorporation into flow cytometry protocols.”
Source: Bio-Rad
Articles in this issue
almost 5 years ago
Intricate Modalities Need More Perceptive Adventitious Agent Testingalmost 5 years ago
Foxx Life Sciences Opens New Headquarters in Indiaalmost 5 years ago
Certara to Open New Office in Chinaalmost 5 years ago
Nanoparticle Dissolution Testing Solution from Agilent Technologiesalmost 5 years ago
Enzo’s New Portable Microplate Reader Simplifies Laboratory WorkflowNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

